Shaanxi Kanghui Pharmaceutical Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Yanling Wang
Chief executive officer
CN¥491.1k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 15.4yrs |
| CEO ownership | n/a |
| Management average tenure | 9.3yrs |
| Board average tenure | 15.4yrs |
Recent management updates
Recent updates
Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Stock Rockets 43% As Investors Are Less Pessimistic Than Expected
Mar 22
Insufficient Growth At Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Hampers Share Price
Sep 30Market Cool On Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues Pushing Shares 28% Lower
Jun 09Little Excitement Around Shaanxi Kanghui Pharmaceutical Co., Ltd.'s (SHSE:603139) Revenues
Feb 27CEO
Yanling Wang (64 yo)
15.4yrs
Tenure
CN¥491,100
Compensation
Mr. Yanling Wang serves as Chairman and General Manager of the Board of Shaanxi Kanghui Pharmaceutical Co., Ltd. since December 11, 2009.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 15.4yrs | CN¥491.10k | no data | |
| Financial Director | 6.4yrs | CN¥147.40k | no data | |
| Deputy GM & Director | 12.1yrs | CN¥277.60k | no data | |
| Deputy GM & Director | no data | CN¥414.70k | 0.055% CN¥ 1.1m | |
| Board Secretary | 3yrs | CN¥133.50k | no data | |
| Accounting Supervisor | no data | no data | no data |
9.3yrs
Average Tenure
48yo
Average Age
Experienced Management: 603139's management team is seasoned and experienced (9.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 15.4yrs | CN¥491.10k | no data | |
| Deputy GM & Director | 15.4yrs | CN¥277.60k | no data | |
| Deputy GM & Director | 4.9yrs | CN¥414.70k | 0.055% CN¥ 1.1m | |
| Director | 15.4yrs | no data | no data | |
| Director | 15.4yrs | no data | no data | |
| Director | 15.4yrs | no data | no data | |
| Chairman of the Supervisory Board | 12.1yrs | no data | no data | |
| Employee Representative Supervisor | 15.4yrs | no data | no data |
15.4yrs
Average Tenure
58yo
Average Age
Experienced Board: 603139's board of directors are seasoned and experienced ( 15.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/19 15:47 |
| End of Day Share Price | 2025/05/19 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shaanxi Kanghui Pharmaceutical Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jiaxi Xu | Industrial Securities Co. Ltd. |